| Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes C Gibbons, J Blundell, S Tetens Hoff, K Dahl, R Bauer, T Bækdal Diabetes, Obesity and Metabolism 23 (2), 581-588, 2021 | 65 | 2021 |
| Adaptive hybrid methods for choice-based conjoint analysis: a comparative study R Bauer, K Menrad, T Decker International Journal of Marketing Studies 7 (1), 1, 2015 | 23 | 2015 |
| Efficacy and safety of oral semaglutide by subgroups of patient characteristics in the PIONEER phase 3 programme VR Aroda, R Bauer, E Christiansen, M Haluzík, K Kallenbach, E Montanya, ... Diabetes, Obesity and Metabolism 24 (7), 1338-1350, 2022 | 22 | 2022 |
| An indirect treatment comparison of semaglutide 2.0 mg vs dulaglutide 3.0 mg and 4.5 mg using multilevel network meta-regression I Lingvay, R Bauer, J Baker-Knight, J Lawson, R Pratley The Journal of Clinical Endocrinology & Metabolism 107 (5), 1461-1469, 2022 | 13 | 2022 |
| Mixed devices in online surveys: Prevalence, determinants, and consequences M Bosnjak, R Bauer, KW Weyandt Mobile Research: Grundlagen und Zukunftsaussichten für die Mobile …, 2018 | 13 | 2018 |
| Präferenzmessung für Automobile mit alternativen Antriebssystemen-Eine Anwendung adaptiver hybrider Verfahren der Choice-based-Conjoint-Analyse R Bauer Technische Universität München, 2015 | 11 | 2015 |
| Are Black Woodpecker (Dryocopus martius) tree cavities in temperate Beech (Fagus sylvatica) forests an answer to depredation risk? V Zahner, R Bauer, TAM Kaphegyi Journal of Ornithology 158, 1073-1079, 2017 | 10 | 2017 |
| Alternative fuel vehicles: Preferences, attitudes, and motives of German students in the field of mobility R Bauer, K Menrad, T Decker International Journal of Electric and Hybrid Vehicles 6 (4), 298-314, 2014 | 9 | 2014 |
| 932-P: efficacy and safety of oral semaglutide by baseline age in the PIONEER clinical trial program VR Aroda, R Bauer, CL Hertz, E Montanya, R SØRRIG, ML Warren, ... Diabetes 69 (Supplement_1), 2020 | 8 | 2020 |
| Incorporating Treatment Pauses, Dosing Flexibility and Education to Support GLP-1RA Therapy Persistence V Aroda, R Bauer, A Davies, E Kreiner, P Lin, R Pratley, S Bain Canadian Journal of Diabetes 45 (7), S6, 2021 | 4 | 2021 |
| Efficacy of oral semaglutide according to baseline HbA1c: an exploratory subgroup analysis of the PIONEER trial programme. Oral presentation# 51 JJ Meier Diabetologia 62 (1), 2019 | 4 | 2019 |
| 57-Efficacy and Safety of Oral Semaglutide by Baseline Age in the PIONEER Clinical Trial Program S Pedersen, VR Aroda, R Bauer, CL Hertz, E Montanya, ML Warren, ... Canadian Journal of Diabetes 44 (7), S24-S25, 2020 | 3 | 2020 |
| Efficacy of oral semaglutide according to diabetes duration: an exploratory subgroup analysis of the PIONEER trial programme M Haluzík, R Bauer, J Eriksson, ST Hoff, K Kallenbach, RE Pratley, J Buse Diab Technol Ther 22 (Suppl 1), A-185, 2020 | 3 | 2020 |
| Efficacy of oral semaglutide according to diabetes duration: an exploratory subgroup analysis of the PIONEER trial programme M Haluzík, R Bauer, JW Eriksson, ST Hoff, K Kallenbach, RE Pratley, ... Diabetologia 62, S26-S26, 2019 | 3 | 2019 |
| 927-P: Effect of Oral Semaglutide with or without Background SGLT2i in Patients with T2D: Subgroup Analysis of PIONEER 4 RE Pratley, R Bauer, SE Inzucchi, K Khunti, EB Kreiner, PN Laursen, ... Diabetes 69 (Supplement_1), 2020 | 2 | 2020 |
| Surrogate endpoint evaluation using data from one large global randomized controlled trial M Geybels, BO Wolthers, FF Kreiner, S Rasmussen, R Bauer BMC Medical Informatics and Decision Making 21 (1), 164, 2021 | 1 | 2021 |
| Efficacy of oral semaglutide according to baseline HbA1c: An exploratory subgroup analysis of the PIONEER trial programme J Meier, R Bauer, T Blicher, I Lingvay, M Treppendahl, B Zinman, ... DIABETES TECHNOLOGY & THERAPEUTICS 22, A68-A68, 2020 | 1 | 2020 |
| POSC317 Multi-Level Network Meta Regression: Some Practical Experiences from an Industry Perspective A Gorst-Rasmussen, J Baker-Knight, R Bauer Value in Health 25 (1), S209-S210, 2022 | | 2022 |
| Incorporating treatment pauses, dosing flexibility and education to support GLP-1RA therapy persistence: data from PIONEER 6 S Bain, R Bauer, AL Davies, EB Kreiner, P Lin, R Pratley, VR Aroda DIABETOLOGIA 64 (SUPPL 1), 253-253, 2021 | | 2021 |
| Efficacy of oral semaglutide according to diabetes duration: An exploratory subgroup analysis of the PIONEER trial programme M Hauser, M Haluzik, R Bauer, J Eriksson, S Hoff, R Pratley, J Buse Diabetologie und Stoffwechsel 16 (S 01), 2021 | | 2021 |
